Foaming alcohol compositions with selected dimethicone surfactants

Information

  • Patent Grant
  • 9980483
  • Patent Number
    9,980,483
  • Date Filed
    Thursday, July 28, 2016
    8 years ago
  • Date Issued
    Tuesday, May 29, 2018
    6 years ago
Abstract
Foaming alcohol compositions with selected dimethicone surfactants are disclosed. The dimethicone surfactants are PEG-8 to PEG-12 linear dimethicone surfactants and in particular PEG-10 linear dimethicone surfactant. The compositions are useful as antimicrobial products and in particular handcare or skincare products.
Description
FIELD OF THE INVENTION

Foaming alcohol compositions with selected dimethicone surfactants are disclosed. The dimethicone surfactants are PEG-8 to PEG-12 linear dimethicone surfactants and in particular PEG-10 linear dimethicone surfactant. The compositions are useful as antimicrobial products and in particular handcare or skincare products.


BACKGROUND

Alcohol compositions are desirable hand and skincare products. They are effective against a wide range of microorganisms such as gram positive and gram negative bacteria and fungi. And they are able to kill microorganisms faster than other antimicrobial products. Alcohol antimicrobial products are available as water thin liquids, gels, emulsions, and aerosol foams. Commercially available aerosol alcohol foams, such as QUIKCARE™, commercially available from Ecolab Inc. (St. Paul, Minn.) rely on propellants to generate the foam. Propellants are needed because the surface tension of alcohol is too low for most surfactants to be able to generate foam and sustain it at atmospheric pressure. But, aerosol products are less desirable because of their inherent drawbacks of not being able to visually monitor the product contents in the container, the additional packaging complexity, and cost. It is desirable to move away from aerosol cans and aerosol propellants to less complex packaging and chemistry that allows a customer to see the product contents in the container while maintaining the aesthetic benefits of a foaming product. It is against this background that the present invention has been made.


SUMMARY

Surprisingly, it has been discovered that PEG-8 to PEG-12 linear dimethicone surfactants and in particular PEG-10 linear dimethicone surfactant are especially effective at generating foam in alcohol products at atmospheric pressure in transparent or translucent, non-aerosol packaging. The PEG-8 to PEG-12 linear dimethicone surfactants are more effective than dimethicone surfactants with the same PEG chain length but a different polymer architecture.


In some embodiments, the invention relates to a non-aerosol antimicrobial composition with a PEG-8 to PEG-12 linear dimethicone surfactant, an alcohol, and water, where the dimethicone can generate an average foam height of greater than 20 mm without needing more than 5% of additional surfactant. In some embodiments, the invention relates to a non-aerosol antimicrobial composition with a PEG-10 linear dimethicone surfactant, an alcohol, and water, where the dimethicone can generate an average foam height of greater than 20 mm without needing more than 5% of additional surfactant. In some embodiments, the composition also contains additional materials such as skin conditioners, terpenoids, chelating agents, and preservatives.


These and other embodiments will be apparent to those of skill in the art and others in view of the following detailed description of some embodiments. It should be understood, however, that this summary, and the detailed description illustrate only some examples of various embodiments, and are not intended to be limiting to the invention as claimed.







DETAILED DESCRIPTION OF SOME EMBODIMENTS

As discussed above, the invention generally relates to foaming alcohol compositions with PEG-8 to PEG-12 linear dimethicone surfactants and in particular PEG-10 linear dimethicone surfactant. The compositions are useful as antimicrobial products and in particular handcare or skincare products.


PEG-8 to PEG-12 Linear Dimethicone Surfactants


Surprisingly, it has been discovered that PEG-8 to PEG-12 linear dimethicone surfactants, and in particular PEG-10 linear dimethicone surfactant, are more effective at generating and stabilizing foam in alcohol compositions than dimethicone surfactants with the same PEG chain length but a different polymer architecture.


More particularly it has been discovered that linear block copolymers of PEG with polydimethylsiloxane (specifically with INCI names of PEG-8 dimethicone, PEG-10 dimethicone, and PEG-12 dimethicone) can produce a sufficient foam height to be used as the primary foaming component of a non-aerosol foaming alcohol compositions, which is not the case for copolymers with the same INCI names but different polymer architectures. For example, polymers with pendant PEG groups or other highly branched polymer structures, will not produce sufficient foam to be used as a primary foaming surfactant. In the case of PEG dimethicone copolymers, linear block copolymers refer to when polyethylene glycol chain units are attached to the terminal ends of the linear polydimethylsiloxane backbone:




embedded image



where R═CH3 or CH2CH3, m=4-20 on average, y=1-5 and n=8-12 on average.


Pendant copolymers refer to linear polydimethylsiloxane polymers with PEG groups attached along the polydimethylsiloxane backbone and may or may not be attached to the terminal chain ends of the polydimethylsiloxane. Such pendant copolymers are often referred to as having a comb or comb-like structure such as:




embedded image



where R is independently=CH3, CH2CH3, or an ethoxylated alkyl chain (for example CH2CH2CH2O(CH2CH2O)nH) attached directly to the silicone end group and a=a repeating silicone group.


Some examples of commercially available PEG-8 to PEG-12 linear dimethicone surfactants include Silsoft 810 (PEG-8) and Silsoft 870 (PEG-12) from Momentive Performance Materials, and Silsurf DI-1010 (PEG-10) from Siltech. In some embodiments, the dimethicone surfactant is preferably a PEG-10 linear dimethicone surfactant.


The dimethicone surfactant can be present in the alcohol composition from about 0.5 to about 10 wt. %, from about 1.0 to about 7 wt. % and from about 2 to about 5 wt. %.


Alcohol


In addition to water, the composition includes an alcohol. The alcohol is preferably a lower chain alcohol such as a C2-C4 alcohol. Examples of suitable alcohols include ethanol, propanols, such as isopropanol and n-propanol, and butanols. The alcohol is preferably ethanol.


The composition may contain one alcohol, or a mixture of two or more alcohols. The alcohol is preferably present in the composition in an amount of active alcohol from about 50 to about 90 wt. %, from about 54 to about 85 wt. %, and from about 60 to about 80 wt. %.


Skin Conditioner


The composition may optionally include at least one skin conditioner such as an emollient, humectant, occlusive agent, or other moisturizer to provide moisturization, skin softening, skin barrier maintenance, anti-irritation, or other skin health benefits. Some non-limiting examples of emollients include alkyl benzoate, myristyl myristate, cetyl myristate, glyceryl dioleate, methyl laurate, PPG-9 laurate, lauryl lacylate allantoin, octyl palmitate, lanolin, propylene glycol, butylenes glycol, ethylene glycol monobutyl ether, glycerine, fatty acids, natural oils such as almond, mineral, canola, sesame, soybean, wheat germ, corn, peanut and olive oil, isopropyl myristate, myristyl alcohol, aloe vera, hydrolyzed silk protein, Vitamin E, stearyl alcohol, isopropyl palmitate, sorbitol, amino acid complexes, hydrolyzed plant proteins, and polyethylene glycol. Some non-limiting examples of humectants include hydroxyethyl urea, agarose, urea, sodium PCA, arginine PCA, fructose, glucose, glutamic acid, glycerine, honey, lactose, maltose, polyethylene glycol, sorbitol and mixtures thereof. Some non-limiting examples of occlusive agents include petrolatum, shea butter, avocado oil, balm mint oil, cod liver oil, mineral oil, trimyristin, stearyl stearate, synthetic wax, or mixtures thereof. Some non-limiting examples of other moisturizers include ethyl hexylglycerin, cholesterol, cystine, hyaluronic acid, keratin, lecithin, egg yolk, glycine, PPG-12, polyquaternium polymers such as polyquaternium-11, benentrimonium chloride, dihydroxypropyl PEG-5 linoleammonium chloride, glycerol oleate, PEG-7 glyceryl cocoate, cocoglucoside, PEG-200 hydrogenated glyceryl palmate, panthenol, retinol, salicylic acid, vegetable oil, methyl gluceth-10, methyl gluceth-20, ethoxylated derivatives of skin conditioners such as glycereth-26 and ethoxylated shea butter, and mixtures thereof. Finally, some non-limiting examples of anti-irritants include bisabolol and panthenol.


A person skilled in the art will recognize the different strengths of different skin conditioners and formulate accordingly. In some embodiments, the skin conditioner is preferably present in the composition in an amount from about 0.01 to about 20 wt. %, from about 0.05 to about 15 wt. %, and from about 0.1 to about 10 wt. %.


Terpenoid


The composition may optionally include a terpenoid. Terpenoids are defined as materials with molecular structures containing carbon backbones made up of isoprene (2-methylbuta-1,3-diene) units. Isoprene contains five carbon atoms and therefore, the number of carbon atoms in any terpenoid is a multiple of five. It is believed that terpenoids assist in promoting the uptake of antimicrobial compounds and preservatives by cells of bacteria and fungi, thereby increasing the efficacy of the antimicrobial compound or preservative. See U.S. Pat. No. 6,319,958 and DE 195 23 320 which are incorporated by reference in their entirety. Some non-limiting examples of terpenoids include α-terpinene, cineole, citral, citronellal, citronellol, farnesol, geraniol, limonene, linalool, methone, nerolidol, terpineol, camphene, menthone, myrcene, nerol, tetrayhydrogeraniol, tetrahydrolinalool, apritone, and bisabolol. The terpenoid is preferably farnesol, nerolidol, bisabolol, or apritone.




embedded image


The terpenoid is preferably present in the composition in an amount from about 0.005 to about 5 wt. %, from about 0.05 to about 2.5 wt. %, and from about 0.1 to about 1.5 wt. %.


Chelating Agent


The composition may optionally include a chelating agent. Examples of chelating agents include phosphonic acid and phosphonates, phosphates, aminocarboxylates and their derivatives, pyrophosphates, ethylenediamine and ethylenetriamine derivatives, hydroxyacids, and mono-, di-, and tri-carboxylates and their corresponding acids. Other chelating agents include nitroloacetates and their derivatives, and mixtures thereof. Examples of aminocarboxylates include amino acetates and salts thereof. Suitable amino acetates include: N-hydroxyethylaminodiacetic acid; hydroxyethylenediaminetetraacetic acid; nitrilotriacetic acid (NTA); ethylenediaminetetraacetic acid (EDTA); N-hydroxyethyl-ethylenediaminetriacetic acid (HEDTA); tetrasodium ethylenediaminetetraacetic acid (EDTA); diethylenetriaminepentaacetic acid (DTPA); and alanine-N,N-diacetic acid; n-hydroxyethyliminodiacetic acid; and the like; their alkali metal salts; and mixtures thereof. Suitable aminophosphates include nitrilotrismethylene phosphates and other aminophosphates with alkyl or alkaline groups with less than 8 carbon atoms. Exemplary polycarboxylates iminodisuccinic acids (IDS), sodium polyacrylates, citric acid, gluconic acid, oxalic acid, salts thereof, mixtures thereof, and the like. Additional polycarboxylates include citric or citrate-type chelating agents, polymeric polycarboxylate, and acrylic or polyacrylic acid-type chelating agents. Additional chelating agents include polyaspartic acid or co-condensates of aspartic acid with other amino acids, C4-C25-mono-or-dicarboxylic acids and C4-C25-mono-or-diamines. Exemplary polymeric polycarboxylates include polyacrylic acid, maleic/olefin copolymer, acrylic/maleic copolymer, polymethacrylic acid, acrylic acid-methacrylic acid copolymers, hydrolyzed polyacrylamide, hydrolyzed polymethacrylamide, hydrolyzed polyamide-methacrylamide copolymers, hydrolyzed polyacrylonitrile, hydrolyzed polymethacrylonitrile, hydrolyzed acrylonitrile-methacrylonitrile copolymers, and the like.


The chelating agent may be present in an amount from about 0.01 to about 5 wt. %, from about 0.05 to about 3 wt. %, and from about 0.1 to about 1.5 wt. %.


Preservatives


The composition may optionally include a preservative. Generally, preservatives fall into specific classes including phenolics, halogen compounds, quaternary ammonium compounds, metal derivatives, amines, alkanolamines, nitro derivatives, biguanides, analides, organosulfur and sulfur-nitrogen compounds, alkyl parabens, and miscellaneous compounds. Some non-limiting examples of phenolic antimicrobial agents include pentachlorophenol, orthophenylphenol, chloroxylenol, p-chloro-m-cresol, p-chlorophenol, chlorothymol, m-cresol, o-cresol, p-cresol, isopropyl cresols, mixed cresols, phenoxyethanol, phenoxyethylparaben, phenoxyisopropanol, phenyl paraben, resorcinol, and derivatives thereof. Some non-limiting examples of halogen compounds include trichlorohydroxy diphenyl ether (Triclosan), sodium trichloroisocyanurate, sodium dichloroisocyanurate, iodine-poly(vinylpyrolidin-onen) complexes, and bromine compounds such as 2-bromo-2-nitropropane-1,3-diol, and derivatives thereof. Some non-limiting examples of quaternary ammonium compounds include benzalkonium chloride, benzethonium chloride, behentrimonium chloride, cetrimonium chloride, and derivatives thereof. Some non-limiting examples of amines and nitro containing compounds include hexahydro-1,3,5-tris(2-hydroxyethyl)-s-triazine, dithiocarbamates such as sodium dimethyldithiocarbamate, and derivatives thereof. Some non-limiting examples of biguanides include polyaminopropyl biguanide and chlorhexidine gluconate. Some non-limiting examples of alkyl parabens include methyl, ethyl, propyl and butyl parabens.


The preservative is preferably present in the composition in an amount from about 0 to about 3 wt. %, from about 0.1 to about 2 wt. %, and from about 0.2 to about 1 wt. %.


Thickener


The composition may optionally include a thickener. Exemplary thickeners include (1) cellulosic thickeners and their derivatives, (2) natural gums, (3) starches, (4) stearates, and (5) fatty acid alcohols. Some non-limiting examples of cellulosic thickeners include carboxymethyl hydroxyethylcellulose, cellulose, hydroxybutyl methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropyl methyl cellulose, methylcellulose, microcrystalline cellulose, sodium cellulose sulfate, and the like. Some non-limiting examples of natural gums include acacia, calcium carrageenan, guar, gelatin, guar gum, hydroxypropyl guar, karaya gum, kelp, locust bean gum, pectin, sodium carrageenan, tragacanth gum, xanthan gum, and the like. Some non-limiting examples of starches include oat flour, potato starch, wheat flour, wheat starch, and the like. Some non-limiting examples of stearates include PEG-150 distearate, methoxy PEG-22/dodecyl glycol copolymer, and the like. Some non-limiting examples of fatty acid alcohols include caprylic alcohol, cetearyl alcohol, lauryl alcohol, oleyl alcohol, palm kernel alcohol, and the like.


The amount of thickener in the composition depends on the desired viscosity of the composition. The composition preferably has a viscosity low enough to pump through a foamer such as an Airspray foamer and allow foaming.


Additional Functional Ingredients


Additional functional ingredients may be used to improve the effectiveness of the composition. Some non-limiting examples of such additional functional ingredients include skin feel improvers, antioxidants, fragrances, dyes, and mixtures thereof.


Skin Feel Improver


The composition may optionally include a skin feel improver for enhancing the “feel” of the composition on a user's skin or hands. For example, it may be undesirable for a composition to have a scaly or gritty texture when applied to a user's skin or after the multiple applications of the composition. Some non-limiting examples of skin feel improvers include silicone copolymers such as amodimethicone, cyclomethicone, bis-PEG/PPG-20/20 dimethicone, and stearoxytrimethylsilane, naturally occurring or synthetic fatty acid esters or ethers, and polyalkylene glycols.


If a skin feel improver is included, it is preferably present in the composition in an amount from about 0.001 to about 5 wt. %, from about 0.01 to about 3 wt. %, and from about 0.1 to about 2 wt. %.


Antioxidant


The composition may optionally include an antioxidant for improved skin condition through the removal of free radicals, and improved product stability. Some non-limiting examples of antioxidants include retinol and retinol derivatives, ascorbic acid and ascorbic acid derivatives, BHA, BHT, betacarotene, cysteine, erythorbic acid, hydroquinone, tocopherol and tocopherol derivatives, and the like.


If an antioxidant is included, it is preferably present in the composition in an amount from about 0.001 to about 2 wt. %, from about 0.01 to about 1 wt. %, and from about 0.05 to about 0.5 wt. %.


Fragrance


The composition may optionally include a fragrance. Examples of possible fragrances include natural oils or naturally derived materials, and synthetic fragrances such as hydrocarbons, alcohols, aldehydes, ketones, esters, lactones, ethers, nitriles, and polyfunctionals. Non-limiting examples of natural oils include the following: basil (Ocimum basilicum) oil, bay (Pimento acris) oil, bee balm (Monarda didyma) oil, bergamot (Citrus aurantium bergamia) oil, cardamom (Elettaria cardamomum) oil, cedarwood (Cedrus atlantica) oil, chamomile (Anthemis nobilis) oil, cinnamon (Cinnamomum cassia) oil, citronella (Cymbopogon nardus) oil, clary (Salvia sclarea) oil, clove (Eugenia caryophyllus) oil, cloveleaf (Eufenia caryophyllus) oil, Cyperus esculentus oil, cypress (Cupressus sempervirens) oil, Eucalyptus citriodora oil, geranium maculatum oil, ginger (Zingiber officinale) oil, grapefruit (Citrus grandis) oil, hazel (Corylus avellana) nut oil, jasmine (Jasminum officinale) oil, Juniperus communis oil, Juniperus oxycedrus tar, Juniperus virginiana oil, kiwi (Actinidia chinensis) water, lavandin (Lavandula hybrida) oil, lavender (Lavandula angustifolia) oil, lavender (Lavandula angustifolia) water, lemon (Citrus medico limonum) oil, lemongrass (Cymbopogon schoenanthus) oil, lime (Citrus aurantifolia) oil, linden (Tilia cordata) oil, linden (Tilia cordata) water, mandarin orange (Citrus nobilis) oil, nutmeg (Myristica fragrans) oil, orange (Citrus aurantium dulcis) flower oil, orange (Citrus aurantium dulcis) oil, orange (Citrus aurantium dulcis) water, patchouli (Pogostemon cablin) oil, peppermint (Menthe piperita) oil, peppermint (Menthe peperita) water, rosemary (Rosmarinus officinalis) oil, rose oil, rose (Rosa damascena) extract, rose (Rosa multiflora) extract, rosewood (Aniba rosaeodora) extract, sage (Salvia officinalis) oil, sandalwood (Santalum album) oil, spearmint (Menthe viridis) oil, tea tree (Melaleuca alternifolia) oil, and ylang ylang (Cananga odorata) oil. Some non-limiting examples of synthetic hydrocarbon fragrances include caryophyllene, β-farnesene, limonene, α-pinene, and β-pinene. Some non-limiting examples of synthetic alcohol fragrances include bacdanol, citronellol, linalool, phenethyl alcohol, and α-terpineol (R═H). Some non-limiting examples of synthetic aldehyde fragrances include 2-methyl undecanal, citral, hexyl cinnamic aldehyde, isocycolcitral, lilial, and 10-undecenal. Some non-limiting examples of synthetic ketone fragrances include cashmeran, α-ionone, isocyclemone E, koavone, muscone, and tonalide. Some non-limiting examples of synethetic ester fragrances include benzyl acetate, 4-t-butylcyclohexyl acetate (cis and trans), cedryl acetate, cyclacet, isobornyl acetate, and α-terpinyl acetate (R=acetyl). Some non-limiting examples of synthetic lactone fragrances include coumarin, jasmine lactone, muskalactone, and peach aldehyde. Some non-limiting examples of synthetic ether fragrances include ambroxan, anther, and galaxolide. Some non-limiting examples of synthetic nitrile fragrances include cinnamonitrile and gernonitrile. Finally, some non-limiting examples of synthetic polyfunctional fragrances include amyl salicylate, isoeugenol, hedione, heliotropine, lyral, and vanillin.


The composition may include a mixture of fragrances including a mixture of natural and synthetic fragrances. The fragrance can be present in a composition in an amount up to about 5 wt. %, preferably from about 0.01 to about 3 wt. %, from about 0.05 to about 1 wt. %, and from about 0.1 to about 0.2 wt. %.


Dye


The composition may optionally include a dye. Examples of dyes include any water soluble or product soluble dye, any FD&C or D&C approved dye. The dye can be present in an amount up to about 0.5 wt. %, preferably from about 0.00001 to about 0.1 wt. %, from about 0.0001 to about 0.01 wt. %, and from about 0.0001 to about 0.0005 wt. %.


Compositions


The non-aerosol alcohol compositions are especially useful as hand and skincare compositions for reducing microorganisms on the target surface.


In some embodiments, the composition includes less than about 10%, less than about 5% or less than about 1% any additional surfactant. The use of additional surfactant may be limited because the selected dimethicone surfactants are capable of producing and maintaining foam without needing help from additional surfactants.


In some embodiments, the composition includes less than about 10%, less than about 5% or less than about 1% any additional silicone materials besides the PEG-8, PEG-10, or PEG-12 linear dimethicone surfactant.


In some embodiments, the composition includes less than about 10%, less than about 5% or less than about 1% any foam stabilizers.


In some embodiments, the composition may be free or substantially free of additional surfactant, additional silicone material, or foam stabilizer. In some embodiments, the composition may be free or substantially free of a fluorosurfactant.


The composition may be provided as a water thin liquid, structured liquid or emulsion. The composition is preferably provided as a ready to use composition, meaning that the composition is provided in a way that can be applied without needing to dilute it first.


Packaging and Dispensers


The composition may be provided in various packaging sizes. Examples of packaging sizes include 1.5 oz, 500 ml and 1 liter bottles. The selected packaging preferably has a pump head foamer. Examples of commercially available pump head foamers include the F2 foamer from Rexam PLC (London, England, formerly Airspray), and the RF-17 Palm Foamer from Rieke Corporation (Auburn, Ind.).


Definitions

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.


All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the term “about” may include numbers that are rounded to the nearest significant figure.


Weight percent, percent by weight, % by weight, wt %, and the like are synonyms that refer to the concentration of a substance as the weight of that substance divided by the weight of the composition and multiplied by 100.


The recitation of numerical ranges by endpoints includes all numbers subsumed within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4 and 5).


As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a composition containing “a compound” includes a mixture of two or more compounds. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


For a more complete understanding of the invention, the following examples are given to illustrate some embodiment. These examples and experiments are to be understood as illustrative and not limiting. All parts are by weight, except where it is contrarily indicated.


EXAMPLES
Example 1—Silicone Surfactant Screening

Example 1 shows various silicone surfactants and their ability to generate a stable foam. The foaming ability of the silicone surfactants was evaluated using the following foam height screening procedure.


Stock Solution Preparation:


A solution consisting of 75.6% Ethanol SDA 40B (190 proof, 99.5% Active) and 24.4% water was prepared.


Sample Preparation:


To a 20 mL vial, approximately 0.35 g of silicone surfactant and 9.65 g Stock solution were weighed. The solution was then mixed until a homogeneous solution was achieved.


Foam Height Screening:


To screen the foam height of each solution, a small portion (˜1 mL) of the prepared solution was placed into a 2 oz bottle with an Airspray foaming pump head, rinsed around, and discarded. After the rinsing of the bottle, the remaining contents of the sample preparation were then transferred into the 2 oz bottle with an Airspray foaming pump head. The foaming pump head was primed until liquid or foam was generated through the foamer head. Up to three additional pumps were performed to ensure that the initial solution had been evacuated through the pump. After priming the pump, three additional pumps were performed, directing the material into a 20 mL glass vial. The height of the foam above the liquid line was immediately measured in millimeters using a ruler. The process was repeated one additional time and the two foam height measurements were averaged. The results are shown in Table 1.









TABLE 1







Silicone Surfactant Screening














chemistry type/
Avg. Foam


Manufacturer
Name
INCI Name
structure
Height (mm)














Noveon
Silsense CA2
dimethicone PEG-7
pendant
9.5




succinate


Noveon
Silsense Q Plus
silicone quaternium-8
pendant
10.5


Noveon
Silsense Copolyol 7
PEG-33 and PEG-14 and
pendant
9




PEG-8 dimethicone


Noveon
Silsense Copolyol 1
PEG-33 and PEG-8
pendant
8.5




dimethicone and PEG-14


Siltech
Silube CS-1
PEG-7
pendant
6.5




dimethiconesuccinate


Siltech
Silphos A-100
silicone polyether
pendant
5




phosphate esters*


Siltech
Silsurf B-208
PEG-8 dimethicone
pendant
5


Siltech
Silsurf A-208
PEG-8 dimethicone
pendant
5.5


Siltech
Silsurf Di-1010
PEG-10 dimethicone
linear
25


Siltech
Silsurf D212-CG
PEG-12 dimethicone
pendant
9


Siltech
Silquat AD
silicone quaternium-8
pendant
4


Siltech
Silquat J208-1B
PEG-8 disteramonium
pendant
8




chloride PG-dimethicone


Degussa
EM 97
bis-PEG/PPG-14/14
alpha, omega
11.5




dimethicone,
omega-




cyclopentasiloxane
polyethersiloxane





linear


Degussa
85
bis-PEG/PPG-16/16
with the addition
15




PEG/PPG-16/16
of caprylic/capric




dimethicone,
acid triglyceride




caprylic/capric,
linear




triglyceride


Degussa
B 8852
PEG/PPG-4/12
pendant




dimethicone


Degussa
B 8832
bis-PEG/PPG-20/20
linear
18




dimethicone


Grant Industries
Gransurf 71
PEG-11 methyl ether
pendant
9




dimethicone


Grant Industries
Gransurf 77
PEG-10 dimethicone
pendant
8


Waker
Waker-Belsil DMC
PEG/PPG-25/25
pendant
8



6031
dimethicone


Waker
Waker-Belsil DMC
bis-PEG 15 methyl ether
methyl ether
3



6038
dimethicone
endcapped linear


Waker
DMC3071VP
cetyl PEG/PPG-15/15
pendant
5




butyl ether dimethicone


Shin Etsu
KF-6100
polyglyceryl-3 disiloxane
pendant
0




dimethicone


Shin Etsu
KF-6017
PEG-10 dimethicone
pendant
12


Shin Etsu
KF-6104
polyglyceryl-3
pendant
0




polydimethylsixethyl




diemethicone


Shin Etsu
KF-6028
PEG-9
pendant
8




polydimethylsiloxane




ethyl dimethicone


Shin Etsu
KF-6015
PEG-3 dimethicone

0


Shin Etsu
KF-6013
PEG-9 dimethicone
pendant
15.5


GE Silicone
Nuwet 300
aminomodified silicone-
pendant
11




polyether copolymer*


GE Silicone
L-7657
PEG dimethicone*
pendant
9


GE Silicone
Silsoft A424
dimethicone bisamino
pendant
0



conditioner
hydroxyethyldihydropropyl




copolyol/TEA




stearate


GE Silicone
L-7001
siloxane
pendant
5




polyalkyleneoxide




copolymer


GE Silicone
Silsoft 430
PEG/PPG 20/23
pendant
18



dimethicone
dimethicone



copolyol


Momentive
Silsoft 805
PEG-8 dimethicone
pendant
17


GE Silicone
Silsoft 840
PEG-8 dimethicone
pendant
7.5


GE Silicone
Silsoft 810
PEG-8 dimethicone
linear
23.5


Momentive
Silsoft 870
PEG-12 dimethicone
linear
24.5


GE Silicone
Silsoft 875
PEG-12 dimethicone
pendant
9


GE Silicone
Silsoft 895
PEG-17 dimethicone
pendant
9.5


Momentive
Silsoft 900
PPG-12 dimethicone
pendant
16.5


Momentive
1188 01P
dimethicone copolyol
pendant
10.5


Momentive
1288 01P
dimethicone copolyol
pendant
13


Rita
Ritasil SP100S
PEG-12 dimethicone
pendant
17


Rita
Ritasil SW3050
cetyl PEG-PPG 10/1
pendant
0




dimethicone


Clariant
Silcare Silicone
trideceth-9 PG
pendant
1



SEA
amodimethicone (and)




trideceth-12


Biosil
Biosil Basics SPQ
silicone quaternium-2
pendant
3.5




panthenol succinate


Biosil
Biosil Basics DL-
dmethiconol pnthenol
pendant
0



30


Biosil
Bioplex Cetyl Sil S
cetyl triethylmonium
pendant
4




dimethicone PEG-8




succinate


Pheonix
DCF-12
PEG-12 dimethicone
pendant
6


chemical





*no INCI name has been given for the polymers







Table 1 shows that only the linear dimethicones are able to produce a foam height greater than 20 mm. Exemplary dimethicone surfactants in Table 1 with a foam height of greater than 20 mm include Silsurf DI-1010 from Siltech, Silsoft 810 from GE Silicone, and Silsoft 870 from Momentive.


Example 2—Foam Height Vs. Silicone Surfactant Concentration

Example 2 determined the effect of dimethicone surfactant concentration on the foam height. For this example, the foam height was measured using the following test:


Stock Solution Preparation:


A solution was prepared with the following formula:
















Stock Solution
(g)



















Ethanol SDA 40 B (190 Proof, 99.5% Active)
811.11



Farnesol
2.78



Bisabolol
1.11



Ethylhexyl glycerin
3.33



Water
181.67











The following amounts were added to 60 mL jars. The silicone surfactants used were Silsurf DI-1010, Silsoft 810, and Silsoft 870.


Sample Preparation:


To a 60 mL jar,



















Sample
1
2
3
4
5
6
7






















Stock solution (g)
22.500
45.00
45.00
45.00
45.00
45.00
45.00


Silicone
0.125
0.50
1.00
1.50
1.75
2.50
5.00


surfactant (g)


Silicone
0.5
1
2
3
3.5
5
10


surfactant (wt. %)


Water (g)
2.375
4.50
4.00
3.50
1.25
2.50
0.00










Foam Height Screening:


To screen the foam height of each solution, a small portion (˜1 mL) of the prepared solution was used to rinse a 2 oz bottle with an Airspray foaming pump head and discarded. After rinsing the bottle, the remaining contents of the sample preparation were then transferred into the 2 oz bottle with an Airspray foaming pump head. The foaming pump head was primed until liquid or foam was generated through the foamer head. Up to three additional pumps were performed to ensure that the rinse solution had been evacuated through the pump. After priming the pump, three additional pumps were performed, directing the material into a 20 mL glass vial. The height of the foam above the liquid line was immediately measured in millimeters using a ruler. The process was repeated and the two foam height measurements were averaged. The results are shown in Table 2.









TABLE 2







Foam Height (mm)














Sample
1
2
3
4
5
6
7

















Silsoft 810
12
11.5
20
24
25.5
26
26


Silsurf DI-1010
14.5
22.5
23.5
24
25
26
26.5


Silsoft 870
13
17
23.5
25.5
26
26
27










Table 2 shows that 0.5-1 gram of silicone surfactant (samples 2 and 3) is preferred in order to generate 20 mm of foam.


The foregoing summary, detailed description, and examples provide a sound basis for understanding the invention, and some specific example embodiments of the invention. Since the invention can comprise a variety of embodiments, the above information is not intended to be limiting. The invention resides in the claims.

Claims
  • 1. A handcare/skincare product comprising: a) a foaming agent comprising a PEG-8 linear dimethicone surfactant;b) a C2 to C4 alcohol, or a mixture of two or more thereof;c) one or more of; alkyl benzoate, myristyl myristate, cetyl myristate, glyceryl dioleate, methyl laurate, PPG-9 laurate, lauryl lacylate allantoin, octyl palmitate, lanolin, propylene glycol, butylenes glycol, ethylene glycol monobutyl ether, glycerine, fatty acids, natural oils, almond oil, mineral oil, canola oil, sesame oil, soybean oil, wheat germ oil, corn oil, peanut oil, olive oil, isopropyl myristate, myristyl alcohol, aloe vera, hydrolyzed silk protein, Vitamin E, stearyl alcohol, isopropyl palmitate, sorbitol, amino acid complexes, hydrolyzed plant proteins, and polyethylene glycol, hydroxyethyl urea, agarose, urea, sodium PCA, arginine PCA, fructose, glucose, glutamic acid, glycerine, honey, lactose, maltose, polyethylene glycol, sorbitol, petrolatum, shea butter, avocado oil, balm mint oil, cod liver oil, mineral oil, trimyristin, stearyl stearate, synthetic wax, ethyl hexylglycerin, cholesterol, cystine, hyaluronic acid, keratin, lecithin, egg yolk, glycine, PPG-12, polyquaternium polymers, polyquaternium-11, benentrimonium chloride, dihydroxypropyl PEG-5 linoleammonium chloride, glycerol oleate, PEG-7 glyceryl cocoate, cocoglucoside, PEG-200 hydrogenated glyceryl palmate, panthenol, retinol, salicylic acid, vegetable oil, methyl gluceth-10, methyl gluceth-20, ethoxylated derivatives of skin conditioners, glycereth-26 and ethoxylated shea butter, bisabolol; andd) water;
  • 2. The handcare/skincare product of claim 1 wherein said C2 to C4 alcohol is in an amount of from about 50 wt. % to about 90 wt. % of said composition.
  • 3. The handcare/skincare product of claim 1, further comprising from about 0.01 to about 20 wt. % of a skin conditioner.
  • 4. The handcare/skincare product of claim 1, wherein the composition is free of an additional surfactant.
  • 5. The handcare/skincare product of claim 1, further comprising from about 0.005 to about 5 wt. % of a terpenoid.
  • 6. The handcare/skincare product of claim 1, wherein said skin product is free of other PEG dimethicone surfactants.
  • 7. A handcare/skincare product comprising: a) a foaming agent comprising a PEG-10 linear dimethicone surfactant;b) a C2 to C4 alcohol, or a mixture of two or more thereof;c) one or more of; alkyl benzoate, myristyl myristate, cetyl myristate, glyceryl dioleate, methyl laurate, PPG-9 laurate, lauryl lacylate allantoin, octyl palmitate, lanolin, propylene glycol, butylenes glycol, ethylene glycol monobutyl ether, glycerine, fatty acids, natural oils, almond oil, mineral oil, canola oil, sesame oil, soybean oil, wheat germ oil, corn oil, peanut oil, olive oil, isopropyl myristate, myristyl alcohol, aloe vera, hydrolyzed silk protein, Vitamin E, stearyl alcohol, isopropyl palmitate, sorbitol, amino acid complexes, hydrolyzed plant proteins, and polyethylene glycol, hydroxyethyl urea, agarose, urea, sodium PCA, arginine PCA, fructose, glucose, glutamic acid, glycerine, honey, lactose, maltose, polyethylene glycol, sorbitol, petrolatum, shea butter, avocado oil, balm mint oil, cod liver oil, mineral oil, trimyristin, stearyl stearate, synthetic wax, ethyl hexylglycerin, cholesterol, cystine, hyaluronic acid, keratin, lecithin, egg yolk, glycine, PPG-12, polyquaternium polymers, polyquaternium-11, benentrimonium chloride, dihydroxypropyl PEG-5 linoleammonium chloride, glycerol oleate, PEG-7 glyceryl cocoate, cocoglucoside, PEG-200 hydrogenated glyceryl palmate, panthenol, retinol, salicylic acid, vegetable oil, methyl gluceth-10, methyl gluceth-20, ethoxylated derivatives of skin conditioners, glycereth-26 and ethoxylated shea butter, bisabolol; andd) water;
  • 8. The handcare/skincare product of claim 7 wherein said C2 to C4 alcohol is in an amount of from about 50 wt. % to about 90 wt. % of said composition.
  • 9. The handcare/skincare product of claim 7, further comprising from about 0.01 to about 20 wt. % of a skin conditioner.
  • 10. The handcare/skincare product of claim 7, wherein the composition is free of an additional surfactant.
  • 11. The handcare/skincare product of claim 7, further comprising from about 0.005 to about 5 wt. % of a terpenoid.
  • 12. The handcare/skincare product of claim 7, wherein said skin conditioner is free of other PEG dimethicone surfactants.
  • 13. The handcare/skincare product of claim 11, wherein said composition is a ready to use composition.
  • 14. The handcare/skincare product of claim 11, wherein said composition is a structured liquid composition.
  • 15. The handcare/skincare product of claim 11, wherein said composition is a water thin liquid composition.
  • 16. A method of reducing microorganisms on skin comprising: applying to said skin a non-aerosol foaming antimicrobial composition comprising: a) a foaming agent comprising a PEG-8 and/or PEG-10 linear dimethicone surfactant;b) a C2 to C4 alcohol, or a mixture of two or more thereof;c) one or more of alkyl benzoate, myristyl myristate, cetyl myristate, glyceryl dioleate, methyl laurate, PPG-9 laurate, lauryl lacylate allantoin, octyl palmitate, lanolin, propylene glycol, butylenes glycol, ethylene glycol monobutyl ether, glycerine, fatty acids, natural oils, almond, mineral, canola, sesame, soybean, wheat germ, corn, peanut oil, olive oil, isopropyl myristate, myristyl alcohol, aloe vera, hydrolyzed silk protein, Vitamin E, stearyl alcohol, isopropyl palmitate, sorbitol, amino acid complexes, hydrolyzed plant proteins, and polyethylene glycol, hydroxyethyl urea, agarose, urea, sodium PCA, arginine PCA, fructose, glucose, glutamic acid, glycerine, honey, lactose, maltose, polyethylene glycol, sorbitol, petrolatum, shea butter, avocado oil, balm mint oil, cod liver oil, mineral oil, trimyristin, stearyl stearate, synthetic wax, ethyl hexylglycerin, cholesterol, cystine, hyaluronic acid, keratin, lecithin, egg yolk, glycine, PPG-12, polyquaternium polymers, polyquaternium-11, benentrimonium chloride, dihydroxypropyl PEG-5 linoleammonium chloride, glycerol oleate, PEG-7 glyceryl cocoate, cocoglucoside, PEG-200 hydrogenated glyceryl palmate, panthenol, retinol, salicylic acid, vegetable oil, methyl gluceth-10, methyl gluceth-20, ethoxylated derivatives of skin conditioners, glycereth-26 and ethoxylated shea butter, bisabolol; andd) water.
  • 17. The method of claim 13 wherein said skin is hand skin.
  • 18. The method of claim 13 wherein said skin is facial skin.
  • 19. The method of claim 16 wherein said composition further comprises a skin conditioning agent.
  • 20. The method of claim 16 wherein said skin conditioning agent is selected from the group comprising: ethylhexylglycerin, hydroxyethylurea, urea, panthenol, glycerin, isopropyl myristate, propylene glycol, tocopheryl acetate, polyquaternium-11 and mixtures thereof.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation application of U.S. Ser. No. 14/496,468 filed Sep. 25, 2014, now U.S. Pat. No. 9,414,586 issued on Aug. 16, 2016, which is a Continuation application of U.S. Ser. No. 14/084,726 filed Nov. 20, 2013, now U.S. Pat. No. 8,940,797, which is a Continuation application of U.S. Ser. No. 13/926,051 filed Jun. 25, 2013, now U.S. Pat. No. 8,658,701 issued Feb. 25, 2014, which is a Continuation application of U.S. Ser. No. 13/742,996 filed Jan. 16, 2013, now U.S. Pat. No. 8,530,524 issued on Sep. 10, 2013, which is a Continuation application of U.S. Ser. No. 13/223,419 filed Sep. 1, 2011, now U.S. Pat. No. 8,383,686 issued on Feb. 26, 2013, which is a Continuation application of U.S. Ser. No. 12/787,624, filed May 26, 2010, now U.S. Pat. No. 8,058,315 issued on Nov. 15, 2011, which is a Continuation of U.S. Ser. No. 12/179,382 filed Jul. 24, 2008, now U.S. Pat. No. 7,842,725, issued Nov. 30, 2010, herein incorporated by reference in their entirety.

US Referenced Citations (247)
Number Name Date Kind
2096837 Baker Oct 1937 A
2198354 Tjaarda Apr 1940 A
2301989 Zamborsky Nov 1942 A
2367719 Gallay Jan 1945 A
2396742 Milliken Mar 1946 A
2410796 Newbery et al. Nov 1946 A
2436414 Arnemo Feb 1948 A
2444870 Clifford Jul 1948 A
2472564 Britten, Jr. Jun 1949 A
2487270 Peterson et al. Nov 1949 A
2516816 Wagner et al. Jul 1950 A
2523207 Fowler et al. Sep 1950 A
2533950 McCormick Dec 1950 A
2539987 Burger Jan 1951 A
2562329 O'Brien Jul 1951 A
2572107 Butin Oct 1951 A
2595025 Tripplehorn Apr 1952 A
2596994 Haberland May 1952 A
2600854 Cross Jun 1952 A
2647311 Arden Aug 1953 A
3787566 Gauvrean Jan 1974 A
4096240 Mathur Jun 1978 A
4220665 Klein Sep 1980 A
4258052 Yu et al. Mar 1981 A
4336151 Like et al. Jun 1982 A
4511486 Shah Apr 1985 A
4714568 Hurnik et al. Dec 1987 A
4725609 Kull, Jr. et al. Feb 1988 A
4758599 Minetti Jul 1988 A
4857302 Decker, Jr. et al. Aug 1989 A
5015228 Columbus et al. May 1991 A
5047249 Rothman et al. Sep 1991 A
5073371 Turner et al. Dec 1991 A
5167950 Lins Dec 1992 A
D338585 Bell et al. Aug 1993 S
5250290 Giacomoni et al. Oct 1993 A
5254331 Mausner Oct 1993 A
5256401 Duckenfield et al. Oct 1993 A
5265772 Bartasevich et al. Nov 1993 A
5266598 Ninomiya et al. Nov 1993 A
D343751 Bell et al. Feb 1994 S
D346332 Kanfer et al. Apr 1994 S
5336497 Guerrero et al. Aug 1994 A
5370267 Schroeder Dec 1994 A
5441178 Wysocki Aug 1995 A
5443236 Bell et al. Aug 1995 A
5449137 Bell et al. Sep 1995 A
5462688 Lippman et al. Oct 1995 A
D365509 Bell et al. Dec 1995 S
D365518 Wysocki Dec 1995 S
D365755 Kanfer et al. Jan 1996 S
5523014 Dolan et al. Jun 1996 A
5558453 Bell et al. Sep 1996 A
5587358 Sukigara et al. Dec 1996 A
5625659 Sears Apr 1997 A
5629006 Hoang et al. May 1997 A
5635462 Fendler et al. Jun 1997 A
D383001 Bell et al. Sep 1997 S
D385795 Wysocki et al. Nov 1997 S
5718353 Kanfer et al. Feb 1998 A
5719113 Fendler et al. Feb 1998 A
D392136 Ross et al. Mar 1998 S
5725131 Bell et al. Mar 1998 A
D400799 Bell et al. Nov 1998 S
5833998 Biedermann et al. Nov 1998 A
5902778 Hartmann et al. May 1999 A
D411456 Mast et al. Jun 1999 S
5939082 Oblong et al. Aug 1999 A
5944227 Schroeder et al. Aug 1999 A
D415343 Maddox Oct 1999 S
5962482 Bissett Oct 1999 A
5968528 Deckner et al. Oct 1999 A
5972356 Peffly et al. Oct 1999 A
D416417 Ross et al. Nov 1999 S
5980921 Biedermann et al. Nov 1999 A
5989523 Fitzjarrell Nov 1999 A
5996851 Dolan et al. Dec 1999 A
5997887 Ha et al. Dec 1999 A
5997890 Sine et al. Dec 1999 A
D418708 Kanfer et al. Jan 2000 S
6022551 Jampani et al. Feb 2000 A
6024942 Tanner et al. Feb 2000 A
D422828 Kanfer et al. Apr 2000 S
6065639 Maddox et al. May 2000 A
6090395 Asmus et al. Jul 2000 A
6130253 Franklin et al. Oct 2000 A
6149925 Mammone et al. Nov 2000 A
6183766 Sine et al. Feb 2001 B1
6217885 Roder et al. Apr 2001 B1
6224888 Vatter et al. May 2001 B1
6265363 Viscovitz Jul 2001 B1
6267976 Barnhart et al. Jul 2001 B1
6274124 Vollhardt Aug 2001 B1
6309657 Vatter et al. Oct 2001 B2
6319958 Johnson et al. Nov 2001 B1
6333039 Fendler et al. Dec 2001 B1
6344218 Dodd et al. Feb 2002 B1
6352701 Scholz et al. Mar 2002 B1
6383505 Kaiser et al. May 2002 B1
6383997 McManus May 2002 B1
6423329 Sine et al. Jul 2002 B1
6432430 Fitzjarrell Aug 2002 B1
6534069 Asmus et al. Mar 2003 B1
6592880 Jager Jul 2003 B1
6607737 Bekele et al. Aug 2003 B2
6613341 Motley et al. Sep 2003 B2
6623744 Asmus et al. Sep 2003 B2
6689593 Millis et al. Feb 2004 B2
6709647 Bhakoo et al. Mar 2004 B2
6723689 Hoang et al. Apr 2004 B1
6846846 Modak et al. Jan 2005 B2
6939552 Ansara et al. Sep 2005 B2
6977082 Seitz, Jr. et al. Dec 2005 B2
6979468 Pollard Dec 2005 B1
7081246 Asmus et al. Jul 2006 B2
7166435 Rosenbloom Jan 2007 B2
7199090 Koivisto et al. Apr 2007 B2
7465697 DeAth Dec 2008 B1
7560422 Shapiro Jul 2009 B2
7569530 Pan et al. Aug 2009 B1
7612115 Suzuki et al. Nov 2009 B2
7651990 Asmus Jan 2010 B2
7795196 Luu et al. Sep 2010 B2
7803390 Asmus et al. Sep 2010 B2
7842725 Wegner et al. Nov 2010 B2
7914774 Meehan Mar 2011 B2
8058315 Wegner et al. Nov 2011 B2
8106094 Sah et al. Jan 2012 B2
8119698 Polonka et al. Feb 2012 B2
8333954 Seidling et al. Dec 2012 B2
8383686 Wegner et al. Feb 2013 B2
8530524 Wegner et al. Sep 2013 B2
8658701 Wegner et al. Feb 2014 B2
8940797 Wegner et al. Jan 2015 B2
9414586 Wegner Aug 2016 B2
20020022660 Jampani et al. Feb 2002 A1
20020168329 Kini et al. Nov 2002 A1
20030023550 Lee Jan 2003 A1
20030049212 Robinson et al. Mar 2003 A1
20030147925 Sawan et al. Aug 2003 A1
20030194447 Scholz et al. Oct 2003 A1
20030203452 Li et al. Oct 2003 A1
20030211066 Scholz et al. Nov 2003 A1
20030215418 Asmus et al. Nov 2003 A1
20040001797 Saud et al. Jan 2004 A1
20040102429 Modak et al. May 2004 A1
20040191274 Grayson et al. Sep 2004 A1
20040247685 Modak et al. Dec 2004 A1
20050053593 Wang et al. Mar 2005 A1
20050058673 Scholz et al. Mar 2005 A1
20050089539 Scholz et al. Apr 2005 A1
20050102266 Nason et al. May 2005 A1
20050142079 Garrison et al. Jun 2005 A1
20060014750 O'Donnell et al. Jan 2006 A1
20060051384 Scholz et al. Mar 2006 A1
20060062832 Lopes Mar 2006 A1
20060094387 Darabi May 2006 A1
20060104911 Novak May 2006 A1
20060104919 Novak May 2006 A1
20060177511 Scholz et al. Aug 2006 A1
20060182690 Veeger et al. Aug 2006 A1
20060193745 Arndt et al. Aug 2006 A1
20060193789 Tamarkin et al. Aug 2006 A1
20060221103 Takanose et al. Oct 2006 A1
20060222502 Hansen et al. Oct 2006 A1
20060229364 Hobbs et al. Oct 2006 A1
20060235798 Alkove et al. Oct 2006 A1
20060281663 Asmus Dec 2006 A1
20070027055 Koivisto et al. Feb 2007 A1
20070065383 Fernandez de Castro et al. Mar 2007 A1
20070076125 Choi et al. Apr 2007 A1
20070148101 Snyder et al. Jun 2007 A1
20070179207 Fernandez de Castro et al. Aug 2007 A1
20070184013 Snyder et al. Aug 2007 A1
20070184016 Macinga et al. Aug 2007 A1
20070185216 Snyder et al. Aug 2007 A1
20070190177 Kling et al. Aug 2007 A1
20070237807 Luu et al. Oct 2007 A1
20070258911 Fernandez de Castro et al. Nov 2007 A1
20070274926 Fuls et al. Nov 2007 A1
20070274940 Fuls et al. Nov 2007 A1
20070275929 Fuls et al. Nov 2007 A1
20070280900 Fox et al. Dec 2007 A1
20070280901 Fuls et al. Dec 2007 A1
20070281039 DeAth Dec 2007 A1
20070281999 Fox et al. Dec 2007 A1
20080004449 Yong et al. Jan 2008 A1
20080026974 Barnhart et al. Jan 2008 A1
20080044479 Stack Feb 2008 A1
20080095814 Taylor et al. Apr 2008 A1
20080108704 Asmus et al. May 2008 A1
20080121355 Pylkki et al. May 2008 A1
20080138438 Taylor et al. Jun 2008 A1
20080139656 Taylor et al. Jun 2008 A1
20080142023 Schmid et al. Jun 2008 A1
20080145390 Taylor et al. Jun 2008 A1
20080199535 Taylor et al. Aug 2008 A1
20080200890 Wood et al. Aug 2008 A1
20080207767 Dobos et al. Aug 2008 A1
20080213198 Lintner et al. Sep 2008 A1
20080213595 Levitt et al. Sep 2008 A1
20080249187 Ali et al. Oct 2008 A1
20080254150 Rheins et al. Oct 2008 A1
20080286223 Fuls et al. Nov 2008 A1
20080287538 Scholz et al. Nov 2008 A1
20090009806 Matsuda Jan 2009 A1
20090012174 Seitz, Jr. et al. Jan 2009 A1
20090018213 Snyder et al. Jan 2009 A1
20090023890 Monahan et al. Jan 2009 A1
20090046116 Davies et al. Feb 2009 A1
20090095821 Feriani et al. Apr 2009 A1
20090104281 Taylor et al. Apr 2009 A1
20090117061 Gross May 2009 A1
20090191248 Hoffman et al. Jul 2009 A1
20090202463 Pan et al. Aug 2009 A1
20090214628 de Rijk Aug 2009 A1
20090226541 Scholz et al. Sep 2009 A1
20090252775 Arndt et al. Oct 2009 A1
20090265230 Plachouras et al. Oct 2009 A1
20090281021 Venkataraman et al. Nov 2009 A1
20090304812 Staniforth et al. Dec 2009 A1
20090324661 Polonka et al. Dec 2009 A1
20090326076 Asmus Dec 2009 A1
20100003198 Stolmeier et al. Jan 2010 A1
20100022654 Asmus et al. Jan 2010 A1
20100029780 Grayson et al. Feb 2010 A1
20100069505 Veeger et al. Mar 2010 A1
20100124280 Chujoh et al. May 2010 A1
20100160453 Koivisto et al. Jun 2010 A1
20100204323 Theiler et al. Aug 2010 A1
20100282409 Hobbs et al. Nov 2010 A1
20100305211 Modak et al. Dec 2010 A1
20100317743 Macinga et al. Dec 2010 A1
20100327013 Asmus Dec 2010 A1
20100331411 Asmus Dec 2010 A1
20100331422 Asmus et al. Dec 2010 A1
20110104079 Snyder et al. May 2011 A1
20110110869 Scholz et al. May 2011 A1
20110144214 Snyder et al. Jun 2011 A1
20110224144 Akil et al. Sep 2011 A1
20110230395 Otto et al. Sep 2011 A1
20110274770 Scholz et al. Nov 2011 A1
20120011468 Zhang Jan 2012 A1
20120121725 Gamier et al. May 2012 A1
20120164087 Carter Jun 2012 A1
20120189684 Buckley et al. Jul 2012 A1
20120208894 Kampf et al. Aug 2012 A1
Foreign Referenced Citations (11)
Number Date Country
19523320 Jan 1997 DE
0396442 Nov 1990 EP
0849070 Jun 1998 EP
0882446 Dec 1998 EP
1811013 Jul 2007 EP
2181187 Jun 2008 EP
1811013 Aug 2009 EP
2005051341 Jun 2005 WO
2006094387 Sep 2006 WO
2006138111 Dec 2006 WO
2009027867 Mar 2009 WO
Non-Patent Literature Citations (15)
Entry
Berfeld, Wilma F., et al., “Safety Assessment of Alkoxy Polysiloxanes as Used in Cosmetics”, Draft Report for Panel Review, (2014), 235 pages.
European Patent Office, “Extended European Search Report”, issued in connection to European Application No. 16158741.5, dated May 31, 2016, 10 pages.
O'Lenick, Tony, “Bis-PEG vs. PEG dimethicone”, Cosmetics and Toiletries, Research, (2007), http://www.cosmeticsandtoiletries.com/research/chemistry/7847427, last accessed on Jul. 28, 2016, 2 pages.
Brehm-Stecher, Johnson, “Sensitization of Staphylococcus aureus and Escherichia coli to Antibiotics by the Sesquiterpenoids Nerolidol, Farnesol, Bisabolol, and Apritone”, University of Wisconsin-Madison, Antimicrobial Agents and Chemotherapy, vol. 47, No. 10, p. 3357-3360. Dec. 31, 2003.
Cosmocil (TM) Folder, 5 pages. Jun. 9, 2014.
Intrinsic Activity of Cosmocil CQ, Avecia, 2 pages. Jun. 9, 2014.
Morton, H., “The Relationship of concentration and germicidal efficiency of ethyl alcohol”, Annals of the New York Academy of Sciences, vol. 52, pp. 191-196, XP008066591, the whole document. Dec. 31, 1950.
Schloss Man, M. (Ed.): “The chemistry and manufacture of cosmetics: formulating. vol. 2, Ed. 3”, Allured Pub., USA 277870, XP002390779, p. 237. Dec. 31, 2000.
Technical Information from BASF for Bisabolol, 8 pages. Nov. 30, 2002.
Technical Specification for Farnesol, Symrise, 2 pages. Jun. 1, 2004.
Search Report for co-pending PCT/IB2009/052871 listing relevant art cited by the International Searching Authority. dated Dec. 31, 2009.
Worldwide Healthcare, Inc., “Material Safety Data Sheet”. Jan. 24, 2007.
European Patent Office, “Supplementary European Search Report”, issued in connection with International Application PCT/IB2009/052871, 7 pages, dated Feb. 28, 2013.
Australian Government, Patent Examination Report No. 1, issued in connection with Patent Application 2009275235, 4 pages, dated Oct. 29, 2014.
Australian Government, Patent Examination Report No. 2, issued in connection with Patent Application 2009275235, 4 pages, dated Feb. 27, 2015.
Related Publications (1)
Number Date Country
20160330955 A1 Nov 2016 US
Continuations (7)
Number Date Country
Parent 14496468 Sep 2014 US
Child 15221779 US
Parent 14084726 Nov 2013 US
Child 14496468 US
Parent 13926051 Jun 2013 US
Child 14084726 US
Parent 13742996 Jan 2013 US
Child 13926051 US
Parent 13223419 Sep 2011 US
Child 13742996 US
Parent 12787624 May 2010 US
Child 13223419 US
Parent 12179382 Jul 2008 US
Child 12787624 US